mdce technology
About Us - The Details
Medical Care Technologies Inc. (OTC : MDCE) is a rapidly advancing diversified company at the intersection of health and technology. The company’s proprietary AI health platform, now patent-pending (U.S. Provisional Patent Application No. 63/854,935), represents a breakthrough in mobile diagnostics. Built on advanced deep learning, temporal image analysis, and affective computing, this platform transforms an ordinary smartphone into a powerful diagnostic tool, enabling real-time health screenings and disease risk detection without the need for specialized equipment.
At Medical Care Technologies Inc. (OTC PINK: MDCE), we are engineering a portfolio of AI-driven healthcare technologies that address some of the most pressing diagnostic gaps across multi-billion-dollar markets. Each vertical is powered by a proprietary patent pending deep learning engine, designed to scale globally and deliver measurable impact for patients, providers, and payers.
- AI Mental Health Screening
Our system integrates high-frame-rate facial landmark tracking, temporal micro-expression analysis, and emotion-recognition neural networks to detect subclinical signs of anxiety, depression, and PTSD that traditional screening often misses. This technology is designed for continuous monitoring through everyday devices like smartphones, providing scalable, cost-effective solutions to a $400+ billion global mental health market projected to grow rapidly due to rising demand for digital therapeutics. - AI Wound Monitoring
By applying sequential imaging algorithms, automated edge detection, and infection risk modeling based on pixel-level segmentation, our AI tool enables early identification of wound deterioration, infection onset, and healing trajectory. This has enormous implications for hospitals, elder care, and diabetic populations, addressing a chronic wound care market already exceeding $20 billion annually and expected to reach over $30 billion by 2030. - AI Skin Cancer Screening
Leveraging full-body lesion indexing, 3D body-mapping algorithms, and temporal skin-change detection, our platform delivers proactive dermatological monitoring at population scale. This tool enhances early melanoma detection, potentially reducing reliance on invasive biopsies while supporting the $15+ billion global dermatology diagnostics and skin cancer screening market. - AI Health Risk Estimator
Using facial biometrics, tonal gradient analysis, and predictive health markers derived from multimodal AI, this vertical estimates disease risk and longevity outlook in real time. The technology empowers insurers, employers, and healthcare providers to forecast health trajectories and intervene earlier, tapping into a preventative healthcare market valued at over $4 trillion globally, with precision health expected to drive exponential growth over the next decade.
Together, these verticals form a scalable, AI-powered health ecosystem targeting multiple high-value markets with disruptive potential to redefine digital diagnostics and preventative healthcare worldwide. We plan to launch our first integrated beta app in 2026, bringing these technologies closer to the hands of consumers and providers.
A.I. Health analysis tools
AI Skin Cancer Screening
Imagine a transformative AI solution that elevates dermatological surveillance by turning routine skin photos into a dynamic, longitudinal body map—intelligently tracking every mole, spot, and lesion across the entire skin surface over time. Unlike traditional tools that analyze individual lesions in isolation, this innovation introduces comprehensive, full-body skin monitoring powered by machine learning, capable of detecting subtle shifts in size, shape, and pigmentation across a patient’s entire dermatological profile. By creating a visual lineage of skin changes, it dramatically improves early detection of melanoma, basal cell carcinoma, and squamous cell carcinoma, while enhancing triage prioritization and long-term screening accuracy. Though clinical dermatology mapping tools exist, a consumer-accessible, AI-integrated lineage tracker remains an open lane for intellectual property and market capture. For tech-savvy investors, this represents a scalable, high-impact opportunity at the nexus of preventive care, computer vision, and personalized health monitoring—where early detection of skin cancers could save lives and reshape global standards in dermatological prevention.
AI Facial Health Risk Estimator
Breakthrough technology that leverages advanced AI to analyze facial imagery and extract biometric signatures—such as micro-wrinkle density, skin elasticity, and tone variations—to generate a real-time estimate of biological age and forecast predisposition to chronic diseases like cardiovascular conditions and diabetes. Beyond systemic health, the platform also supports early detection and monitoring of vision-related conditions such as glaucoma, cataracts, and diabetic retinopathy, delivering a more comprehensive preventive care approach. This innovation fuses visual facial data with predictive health biomarkers into a seamless diagnostic workflow, offering a highly personalized, non-invasive risk assessment tool that could fundamentally shift how preventive medicine is delivered. By integrating ocular, dermatological, and systemic health insights, the technology creates a unified framework for holistic well-being. This frontier-level application represents a scalable opportunity at the intersection of computer vision, digital diagnostics, and proactive health optimization—far beyond conventional screening tools.
AI Micro-Expression Mental Health Screening
Envision a next-generation health technology that harnesses AI-driven facial micro-expression analysis to detect subtle, often imperceptible emotional shifts—captured through a simple selfie video—that correlate with early indicators of depression, anxiety, or PTSD. Beyond mental health, the platform extends its capabilities to the early detection and ongoing monitoring of neurological conditions such as dementia and Parkinson’s disease. By analyzing both facial cues and speech prompts, the system can identify vocal tremors, hesitations, memory-related pauses, and tone variations that may serve as early biomarkers of cognitive or motor decline. This cutting-edge solution merges facial coding systems with affective computing and advanced voice analytics to flag potential psychological or neurological distress before traditional self-reporting or clinical symptoms emerge. By enabling early, scalable screening through telehealth platforms, educational institutions, or even wearable integrations, this innovation offers a disruptive path forward in preventive care—one where emotion-sensing algorithms and voice-based diagnostics empower real-time, accessible health insights. For forward-looking investors, it represents a rare intersection of artificial intelligence, digital therapeutics, and mass-accessibility in a global health market that remains vastly underserved.
AI Wound-Healing Monitor for Home Care
Picture an AI-powered health solution that transforms everyday smartphone cameras into intelligent wound monitoring tools—capturing sequential images of chronic wounds like diabetic ulcers to track healing trajectories, detect infection risks, and identify stagnation or deterioration in real time. This system leverages automated segmentation, edge detection, and visual pattern recognition to quantify progress with clinical-level precision, all without requiring in-person evaluation. Its true innovation lies in empowering non-clinical users—patients, caregivers, and remote practitioners—with data-driven insights that enable earlier interventions, reduce hospital visits, and improve outcomes. While institutional-grade wound assessment tools exist, the consumer-facing, mobile-first version of this technology remains largely untapped.
CEo - Marshall H. Perkins III
CEO Profile
Marshall Perkins is the CEO of Medical Care Technologies Inc., Infinite Auctions, and Real Game Used, where he leads with vision, resilience, and purpose.
In early 2025, Marshall endured a near-fatal battle with advanced bone cancer that destroyed multiple vertebrae and left him hospitalized for months. At the same time, he faced the devastation of vitiligo. Against all odds, he made a full and miraculous recovery — learning to walk again, beating cancer, and even reversing the skin condition once thought permanent. A walking miracle with a re-ignited purpose in Medical Care Technologies Inc.
Today, Marshall channels this extraordinary second chance into innovation and impact. He works hand-in-hand with a dedicated team of medical experts, medical students, and tech innovators, collaborating daily to push the boundaries of what’s possible in healthcare and technology.
Having nearly lost his life to an unexpected health crisis, Marshall knows firsthand how quickly everything can change. He doesn’t want others to be blindsided the way he was — and that experience has made him more motivated than ever to ensure others have the tools, knowledge, and support to protect their health before it’s too late.
OTC Ticker: MDCE - Contact us for Inquiries
Turn your smart device into a personal AI doctor
We can use photos, voice scans, and smiles to empower your health with potentially life-saving precision. Visit www.mdcestock.com for information on our other successful subsidiaries.
Medical Care Technologies Inc.
1910 South Stapley Drive suite 221, Mesa, AZ 85204, USA
